UnitedHealth and Amedisys Extend Merger Deadline UnitedHealth Group and Amedisys have extended the deadline on their $3.3 billion merger proposal, impacting the healthcare M&A landscape.
BioNTech Settles Lawsuit with UPenn for $467 Million BioNTech agrees to pay $467 million to the University of Pennsylvania, resolving a legal dispute. Learn more about this significant pharmaceutical settlement.
BioNTech Settles $791.5M Payment to NIH BioNTech to pay $791.5 million to the U.S. National Institutes of Health. Explore the significance of this large-scale healthcare royalty settlement.
BioNTech Settles Vaccine Royalty Disputes with NIH and UPenn BioNTech reaches settlements with NIH and University of Pennsylvania over COVID-19 vaccine royalties, marking a significant legal resolution in healthcare.
UnitedHealth and Amedisys Extend Merger Agreement UnitedHealth and Amedisys have agreed to extend their merger agreement, highlighting a commitment to finalize the healthcare M&A deal.
UnitedHealth and Amedisys Reaffirm Merger Commitment UnitedHealth and Amedisys strengthen their merger agreement by waiving termination rights, signaling a firm path forward in healthcare M&A.
Sectoral Equity Funds Face Outflows Amid Challenges Sectoral equity funds, particularly in healthcare and consumer discretionary, face continued outflows. Discover the sector-specific challenges driving these trends.
Sectoral Equity Funds Experience $2.14 Billion Outflows Discover why sectoral equity funds, particularly in healthcare and consumer discretionary, faced $2.14 billion in net outflows.
Healthcare Stocks Climb: CVS and Walgreens Surge Healthcare stocks experienced a rise with CVS Health increasing by 1.5% and Walgreens Boots Alliance surging by 5.3%, marking a significant uptick in the sector.
Retail and Healthcare Stocks Cushion Market Losses Discover how gains in retail and healthcare stocks helped mitigate market losses. Explore the impact of these sectors on the stock market today.